Form 4: Clene Director Wilcox Granted Stock Options

Clene Inc. Director Reed Wilcox received a grant of 1,893 stock options with an exercise price of $7.30 per share, vesting immediately.

Summary

• Reed N. Wilcox, a Director of Clene Inc. (CLNN), was granted stock options.
• The transaction occurred on November 13, 2025.
• The grant was for 1,893 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan.
• The exercise price for these options is $7.30 per share.
• The options vest immediately upon grant.
• Following this transaction, Reed N. Wilcox beneficially owns 1,893 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The filing reports a routine insider compensation event (stock option grant) which is neutral in sentiment, reflecting standard corporate governance and compensation practices without indicating specific positive or negative operational performance.

Positives

• The immediate vesting of the options provides the director with immediate equity exposure.
• The grant aligns the director's financial interests with the long-term performance and shareholder value of Clene Inc.

Negatives

• The value of the options is entirely dependent on Clene Inc.'s future stock price exceeding the $7.30 exercise price.
• There is no immediate cash benefit to the director from this grant.

Risks

• The stock options could expire worthless if Clene Inc.'s share price does not rise above the exercise price of $7.30 before the expiration date.
• Market volatility and company-specific performance could negatively impact the value of the options.

Future Outlook

This filing does not contain specific forward-looking statements or guidance beyond the terms of the stock option grant itself.

Industry Context

The grant of stock options to directors is a common practice in the biotechnology and pharmaceutical industries to incentivize long-term commitment and align leadership interests with shareholder value creation.

Comparison to Industry Standards

• N/A. This filing details a specific individual compensation event rather than company-wide performance metrics that would allow for direct comparison to industry benchmarks or competitor results.

Corporate Governance

Stakeholder Impact

• Shareholders may view this as a positive step towards aligning director incentives with long-term company performance and shareholder value creation.

Key Dates

Keywords

Clene Inc., CLNN, stock option, director compensation, insider transaction, equity grant, beneficial ownership